Related Experiment Video
Updated: Dec 10, 2025

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
Molecular and Cellular Mechanisms Affected in ALS
Laura Le Gall1,2, Ekene Anakor1, Owen Connolly1
1Northern Ireland Center for Stratified/Personalised Medicine, Biomedical Sciences Research Institute, Ulster University, Derry-Londonderry BT47, UK.
Amyotrophic lateral sclerosis (ALS) involves motor neuron loss. This review explores shared molecular pathways, like mitochondrial dysfunction and RNA metabolism, implicated in familial and sporadic ALS, aiding therapeutic development.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting motor neurons.
- Genetic mutations account for ~20% of ALS cases, highlighting the need to understand broader molecular mechanisms.
- Familial and sporadic ALS may share underlying cellular pathway dysfunctions.
Purpose of the Study:
- To review and synthesize current knowledge on molecular pathways implicated in ALS pathogenesis.
- To explore common mechanisms across different forms of ALS.
- To identify potential therapeutic targets by understanding shared molecular pathways.
Main Methods:
- Literature review of studies investigating ALS-associated genes and cellular processes.
- Detailed discussion of key pathways including mitochondrial dysfunction, oxidative stress, and RNA metabolism.
- Analysis of mechanistic roles of ALS genes within these pathways.
Main Results:
- Mutations in over 30 genes are linked to ALS, affecting diverse cellular functions.
- Key implicated pathways include mitochondrial dysfunction, oxidative stress, axonal transport, excitotoxicity, endosomal transport, protein homeostasis, and RNA metabolism.
- Understanding these shared pathways offers insights into both inherited and sporadic ALS.
Conclusions:
- A cohesive understanding of shared molecular pathways is crucial for developing effective ALS therapies.
- Investigating common mechanisms provides a unified approach to tackling ALS heterogeneity.
- Targeting these fundamental cellular processes may offer therapeutic benefits for a wider range of ALS patients.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Parkinson's Disease: Overview
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Multiple Allele Traits

